BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38320046)

  • 1. Osmotic Demyelination Syndrome in Patients Hospitalized with Hyponatremia.
    MacMillan TE; Shin S; Topf J; Kwan JL; Weinerman A; Tang T; Raissi A; Koppula R; Razak F; Verma AA; Fralick M
    NEJM Evid; 2023 Apr; 2(4):EVIDoa2200215. PubMed ID: 38320046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients presenting with severe hypotonic hyponatremia: etiological factors, assessment, and outcomes.
    Vu T; Wong R; Hamblin PS; Zajac J; Grossmann M
    Hosp Pract (1995); 2009 Dec; 37(1):128-36. PubMed ID: 20877181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Factors and Outcomes of Rapid Correction of Severe Hyponatremia.
    George JC; Zafar W; Bucaloiu ID; Chang AR
    Clin J Am Soc Nephrol; 2018 Jul; 13(7):984-992. PubMed ID: 29871886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osmotic demyelination syndrome following correction of hyponatremia: association with hypokalemia.
    Lohr JW
    Am J Med; 1994 May; 96(5):408-13. PubMed ID: 8192171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osmotic Demyelination Syndrome following Correction of Hyponatremia by ≤10 mEq/L per Day.
    Tandukar S; Sterns RH; Rondon-Berrios H
    Kidney360; 2021 Sep; 2(9):1415-1423. PubMed ID: 35373113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azotemia protects the brain from osmotic demyelination on rapid correction of hyponatremia.
    Dhrolia MF; Akhtar SF; Ahmed E; Naqvi A; Rizvi A
    Saudi J Kidney Dis Transpl; 2014 May; 25(3):558-66. PubMed ID: 24821152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correction of hyponatremia and osmotic demyelinating syndrome: have we neglected to think intracellularly?
    Pham PM; Pham PA; Pham SV; Pham PT; Pham PT; Pham PC
    Clin Exp Nephrol; 2015 Jun; 19(3):489-95. PubMed ID: 25150510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Criteria for Hyponatremic Overcorrection: Systematic Review and Cohort Study of Emergently Ill Patients.
    Woodfine JD; van Walraven C
    J Gen Intern Med; 2020 Jan; 35(1):315-321. PubMed ID: 31452039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osmotic demyelination syndrome following correction of hyponatremia.
    Sterns RH; Riggs JE; Schochet SS
    N Engl J Med; 1986 Jun; 314(24):1535-42. PubMed ID: 3713747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osmotic Demyelination Syndrome in a Patient with Diabetic Ketoacidosis despite No Rapid Sodium Correction.
    Nakanishi T; Tamaru S; Harada T; Shukuya K; Yamasato K; Kataoka J; Makita K; Nakai M
    Intern Med; 2024 Jun; 63(11):1591-1596. PubMed ID: 37866918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Osmotic demyelination syndrome and overly rapid correction of hyponatremia].
    Grosjean A; Thieffry C; Marti C
    Rev Med Suisse; 2022 Oct; 18(801):2012-2018. PubMed ID: 36314091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osmotic demyelination syndrome: are patients with end-stage liver disease a special risk group?
    Verbeek TA; Stine JG; Saner FH; Bezinover D
    Minerva Anestesiol; 2020 Jul; 86(7):756-767. PubMed ID: 32013329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Serum Sodium Correction Rates for Management of Hyponatremia in Hospitalized Patients.
    Pham CT; Kassab HS; Johnston JP
    Ann Pharmacother; 2022 Feb; 56(2):131-138. PubMed ID: 34027713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Tolvaptan to Treat Hyponatremia: Results from a Post-authorization Pharmacovigilance Study.
    Estilo A; McCormick L; Rahman M
    Adv Ther; 2021 Dec; 38(12):5721-5736. PubMed ID: 34693505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minocycline prevents osmotic demyelination associated with aquaresis.
    Takagi H; Sugimura Y; Suzuki H; Iwama S; Izumida H; Fujisawa H; Ogawa K; Nakashima K; Ochiai H; Takeuchi S; Kiyota A; Suga H; Goto M; Banno R; Arima H; Oiso Y
    Kidney Int; 2014 Nov; 86(5):954-64. PubMed ID: 24759153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic challenges in the management of osmotic demyelination syndrome: A case report of a favorable outcome from a tertiary center.
    Elshafei M; Danjuma MI; Tahir RE
    Medicine (Baltimore); 2020 Jun; 99(24):e20283. PubMed ID: 32541452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of the Osmotic Demyelination Syndrome After Liver Transplantation: A Multidisciplinary Perspective.
    Crismale JF; Meliambro KA; DeMaria S; Bronster DB; Florman S; Schiano TD
    Am J Transplant; 2017 Oct; 17(10):2537-2545. PubMed ID: 28422408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osmotic demyelination syndrome.
    King JD; Rosner MH
    Am J Med Sci; 2010 Jun; 339(6):561-7. PubMed ID: 20453633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspective.
    Sterns RH; Cappuccio JD; Silver SM; Cohen EP
    J Am Soc Nephrol; 1994 Feb; 4(8):1522-30. PubMed ID: 8025225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Osmotic demyelination syndrome following slow correction of hyponatraemia.
    Saunders I; Williams DM; Ruslan AM; Min T
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34373247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.